Rotator cuff tear is one of the most common shoulder conditions affecting modern adults. This condition arises from tendon damage caused by prolonged smartphone and computer use, poor posture, and repetitive shoulder movements. As time progresses, the tear range expands, making treatment increasingly challenging.

Against this backdrop, REGENETEN therapy has emerged as a breakthrough solution. REGENETEN involves implanting a bio-inductive collagen implant over the damaged tendon, which is absorbed by the body and induces regeneration into healthy tendon tissue. For partial tears, patients can return to daily activities within approximately one month using REGENETEN alone, without suturing. Even when combined with sutures REGENETEN implantation enables a return to daily life within 3-4 months. The most significant advantage lies in the shortened recovery period, allowing patients to resume athletic activities within 4-5 months.

Furthermore, patients who receive REGENETEN treatment maintain regenerative capacity for up to six months even after a re-tear. These results demonstrate that the treatment’s effects extend well beyond the short term. However, proper surgical procedures and rehabilitation therapy, conducted by specialized medical staff, must accompany treatment, with active patient cooperation remaining the most critical factor.

Located in Yuseong-gu, Daejeon, Baroseum Hospital (Medical Director Kyung-hoon Kim) was the first in Korea to perform Regeneten procedures and has conducted more than any other institution, accumulating unparalleled clinical data in the field. The hospital's particular strengths include △specialized medical staff with extensive surgical experience, △precision diagnostic systems utilizing state-of-the-art equipment, and △patient-customized treatment with systematic rehabilitation program operations. Many patients at Baroseum Hospital have experienced relief from pain and a rapid return to their daily lives, reporting high satisfaction rates.

While health insurance coverage is not yet available domestically, Japan has already established this as a proven treatment method with insurance coverage. These international cases further validate the reliability of Regeneten treatment that Baroseum Hospital has pioneered and advanced.

With patient-centered, specialized medical services and differentiated expertise, Baroseum Hospital has emerged as a leading healthcare institution that represents Daejeon’s competitive edge in the medical tourism sector.